The invention refers to the method of using bst1 (ADP ribosil cycloasa 2) antibody and similar citidina or one of its pharmaceutically acceptable salts, and the method of using bst1 (ADP ribosil cycloasa 2) and / or activity to treat moderate cancer and other diseases. It is related to the expression / abnormal activity of bst1.
展开▼
